3 Male and female patients will be eligible for enrollment Females should be either of nonchildbearing potential as a result of surgery or menopause 1 year after onset or of childbearing potential and practicing a medically acceptable method of contraception e.g. abstinence a barrier method plus spermicide or intrauterine device IUD for at least 1 month before Visit 1 Screening and for 1 month after the end of the study They must also have a negative serum beta-human chorionic gonadotropin B-hCG at Screening Those females using hormonal contraceptives must also be using an additional approved method of contraception e.g. a barrier method plus spermicide or IUD starting with the Baseline Phase and continuing throughout the entire study period 